Latest Research on Tablets: April 21

Posted on April 21, 2021Categories Medical ScienceTags   Leave a comment on Latest Research on Tablets: April 21

[1] Vindolanda tablets The Latin writing tablets from Vindolanda, a Roman auxiliary fort about a mile south of Hadrian’s Wall, were discovered by the archaeologist R. E. Birley in excavations of parts of the pre‐Hadrianic timber forts during the period 1974–2004. [2] Orally Disintegrating Tablets: A Review Drug delivery systems are becoming increasingly sophisticated as pharmaceutical scientists acquire a better understanding of the physicochemical and biochemical parameters pertinent to their performance. Over the past three decades, orally disintegrating tablets (ODTs) … Continue reading “Latest Research on Tablets: April 21”

Latest News on Doxorubicin Research: Dec – 2019

Posted on December 16, 2019Categories Medicine and PharmacyTags ,   Leave a comment on Latest News on Doxorubicin Research: Dec – 2019

Doxorubicin-Induced Cardiomyopathy Doxorubicin (Adriamycin) has been employed in medical specialty observe since the late Nineteen Sixties. It control promise as a strong drug within the fight against cancer. The tumors most typically responding to antibiotic drug once it’s given as one agent or together with different antitumour agents embody breast and muscular structure carcinomas; sarcoma, Kaposi’s sarcoma, and soft-tissue sarcomas; and Hodgkin’s and non-Hodgkin’s lymphomas. different cancers that square measure less awake to antibiotic drug however that square measure still … Continue reading “Latest News on Doxorubicin Research: Dec – 2019”

Latest News on Bisoprolol Research: Dec – 2019

Posted on December 9, 2019Categories Medicine and PharmacyTags ,   Leave a comment on Latest News on Bisoprolol Research: Dec – 2019

Balanced pharmacokinetics and metabolism of bisoprolol. Bisoprolol exhibits a high absolute bioavailability (90%) thanks to its nearly complete absorption (greater than 90%) and tiny first-pass impact (10%). Bioavailability is freelance of food intake. a protracted plasma-elimination half-life (10-11h) permits a once-a-day dose programme. thanks to the low plasma protein-binding (30%), mechanics area unit insensitive to protein-binding interactions. The balanced clearance (equieffective internal organ and nephritic clearance) renders the mechanics just about insensitive to nephritic or internal organ insufficiency. Even within … Continue reading “Latest News on Bisoprolol Research: Dec – 2019”

News Update on Atorvastatin Research: Dec – 2019

Posted on December 2, 2019Categories Medicine and PharmacyTags ,   Leave a comment on News Update on Atorvastatin Research: Dec – 2019

Comparison of One-Year Efficacy and Safety of Atorvastatin Versus Lovastatin in Primary Hypercholesterolemia This double-blind procedure to guage semipermanent effectiveness Associate in Nursingd safety of lipid-lowering medication was performed in thirty one community- and university-based analysis centers within the USA to directly compare a replacement 3-hydroxy-3-methylglutaryl-coenzyme A enzyme substance (reductase inhibitor) to an accepted drug of this category in patients with moderate hypercholesteremia. Participants remained on a cholesterol-lowering diet throughout the study. One thousand 49 patients were irregular to receive … Continue reading “News Update on Atorvastatin Research: Dec – 2019”

Latest Research News on Atorvastatin: Nov – 2019

Posted on November 27, 2019Categories Medicine and PharmacyTags ,   Leave a comment on Latest Research News on Atorvastatin: Nov – 2019

Comparison of One-Year Efficacy and Safety of Atorvastatin Versus Lovastatin in Primary Hypercholesterolemia This double-blind procedure to guage semipermanent effectivity associate degreed safety of lipid-lowering medicine was performed in thirty one community- and university-based analysis centers within the USA to directly compare a replacement 3-hydroxy-3-methylglutaryl-coenzyme A enzyme matter (reductase inhibitor) to an accepted drug of this category in patients with moderate hypercholesteremia. Participants remained on a cholesterol-lowering diet throughout the study. One thousand cardinal patients were irregular to receive lipid-lowering … Continue reading “Latest Research News on Atorvastatin: Nov – 2019”

Latest Research News on Artesunate: Nov – 2019

Posted on November 16, 2019Categories Medicine and PharmacyTags ,   Leave a comment on Latest Research News on Artesunate: Nov – 2019

Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border Resistance to several antimalaria medicine developed on the Cambodia–Thailand border long before developing elsewhere. as a result of antimalaria resistance is currently a world downside, artemisinin-based combination therapies (ACTs) area unit the first-line therapies in most malaria-endemic countries. However, recent clinical and molecular studies counsel the emergence of ACT-resistant Plasmodium falciparum infections within the Cambodia–Thailand border space, wherever commonplace ACT is artesunate and mefloquine hydrochloride. These ACT failures could be … Continue reading “Latest Research News on Artesunate: Nov – 2019”

Latest Research News on Atenolol: Oct – 2019

Posted on October 31, 2019Categories Medicine and PharmacyTags ,   Leave a comment on Latest Research News on Atenolol: Oct – 2019

Phenelzine vs Atenolol in Social Phobia: A Placebo-Controlled Comparison Seventy-four patients World Health Organization met DSM-III criteria for phobia completed eight weeks of double-blind, haphazardly appointed treatment with the MAO matter Nardil sulphate, the cardioselective β-adrenergic blocker Tenormin, or placebo. the response rates were sixty fourth for Nardil, half-hour for Tenormin, and twenty third for placebo. Nardil was wide superior to each Tenormin and placebo on freelance rater analyses and, to a lesser extent, on self-report, with no important variations … Continue reading “Latest Research News on Atenolol: Oct – 2019”

Latest Research News on Indomethacin: Oct – 2019

Posted on October 25, 2019Categories Medicine and PharmacyTags ,   Leave a comment on Latest Research News on Indomethacin: Oct – 2019

“Hemicrania continua”: another headache absolutely responsive to indomethacin Two cases plagued by a headache apparently discrepant with well recognized headaches area unit delineated . it’s characterised by a gradual, non‐paroxysmal, in all probability severe to moderately severe head ache localized anteriorly or anteroposteriorly and isn’t related to nausea. nonsteroidal {anti-inflammatory|nonsteroidal anti-inflammatory drug|NSAID} exerts an absolute, persistent and clearly dose‐dependent result on this headache, that differs from unilateral headache syndromes like headache and cervicogenic headache in its temporal pattern and nonsteroidal … Continue reading “Latest Research News on Indomethacin: Oct – 2019”

Latest News on Dosage Form Research: Oct – 2019

Posted on October 2, 2019October 2, 2019Categories Medicine and PharmacyTags ,   Leave a comment on Latest News on Dosage Form Research: Oct – 2019

Drug‐delivery Products and the Zydis Fast‐dissolving Dosage Form Many patients notice it troublesome to swallow tablets and exhausting gelatin capsules and don’t take their medication as prescribed. it’s calculable that fifty of the population is stricken by this downside which ends up during a high incidence of non‐compliance and ineffective medical care. the problem is knowledgeable above all by medical specialty and geriatric patients, however it conjointly applies to UN agency|people that|folks that|those that|those who} ar sick in bed and … Continue reading “Latest News on Dosage Form Research: Oct – 2019”